Background illustration for clinical trials search

Paid Clinical Trials Indianapolis

Discover 874 paid clinical trials in Indianapolis, Indiana. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2
Active & Responsive

CorMatrix Cor TRICUSPID ECM Valve Replacement Study

for
Tricuspid Valve Disease
Location: Indianapolis IN, Cincinnati OH, Baltimore MD, Mobile AL
Sponsor: CorMatrix Cardiovascular, Inc.

Sex: All

Age: 1 - 70+

Code: NCT02397668

Recruiting
Active & Responsive

A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009)

for
Carcinoma, Non-Small-Cell Lung
Location: Indianapolis IN, Cincinnati OH, Chicago IL,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06623422

Phase3, Recruiting
Active & Responsive

A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer

for
Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or Cancer,
Location: Indianapolis IN, Edgewood KY, Chicago IL, Ann Arbor MI,
Sponsor: Astellas Pharma Global Development, Inc.

Sex: All

Age: 18+

Code: NCT06901531

Phase3, Recruiting
Active & Responsive

A Study to Investigate the Effect of Mitapivat on Transfusion Burden in Subjects With Sickle Cell Disease (SCD)

for
Sickle Cell Disease
Location: Indianapolis IN, Grand Rapids MI, Flowood MS
Sponsor: Agios Pharmaceuticals, Inc.

Sex: All

Age: 12+

Code: NCT07656415

Phase3, Recruiting
Active & Responsive

Prevention of Bleeding in Patients With Moderate and Severe Hemophilia A Playing Sports: A Comparison Between Factor VIII and Emicizumab Prophylaxis

for
Hemophilia A
Location: Indianapolis IN, Cincinnati OH, Chicago IL, Detroit MI,
Sponsor: Wayne State University

Sex: All

Age: 6 - 19

Code: NCT05022459

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image
Active & Responsive

Emicizumab for Severe Von Willebrand Disease (VWD) and VWD/Hemophilia A

for
Von Willebrand Disease, Type 3, Concomitant VWD and Hemophilia
Location: Indianapolis IN, Peoria IL, Ann Arbor MI,
Sponsor: Bleeding and Clotting Disorders Institute Peoria, Illinois

Sex: All

Age: 0 - 70+

Code: NCT05500807

Phase1, Recruiting
Active & Responsive

CORCYM Mitral, Aortic aNd Tricuspid Post-maRket Study in a reAl-world Setting

for
Cardiac Valve Disease
Location: Indianapolis IN, Cleveland OH, Toronto, Durham NC,
Sponsor: Corcym S.r.l

Sex: All

Age: 0+

Code: NCT05002543

Recruiting
Active & Responsive

Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer

for
Advanced Endometrial Carcinoma, Recurrent Endometrial Carcinoma
Location: Indianapolis IN, Danville IL, Urbana IL, Mattoon IL,
Sponsor: National Cancer Institute (NCI)

Sex: Female

Age: 18+

Code: NCT07198074

Phase3, Recruiting
Active & Responsive

The Artisse™ Intrasaccular Device is Indicated for the Treatment of Wide-neck Bifurcating Intracranial Aneurysms (IAs).

for
Intracranial Aneurysm
Location: Indianapolis IN, Chicago IL, Cleveland OH, Iowa City IA,
Sponsor: Medtronic Neurovascular Clinical Affairs

Sex: All

Age: 18 - 70+

Code: NCT02998229

Recruiting
Active & Responsive

Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity

for
Heart Failure With Preserved Ejection Fraction,
Location: Indianapolis IN, Richmond IN, Elkhart IN, Munster IN,
Sponsor: Amgen

Sex: All

Age: 18 - 70+

Code: NCT07037459

Phase3, Recruiting
Active & Responsive

Assessment of CCM in HF With Higher Ejection Fraction

for
Heart Failure, Heart Failure With Preserved Ejection Fraction,
Location: Indianapolis IN, Lexington KY, Columbus OH,
Sponsor: Impulse Dynamics

Sex: All

Age: 18+

Code: NCT05064709

Recruiting
Active & Responsive

Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure

for
Heart Failure, Heart Diseases, Cardiovascular Diseases,
Location: Indianapolis IN, Cincinnati OH, Louisville KY,
Sponsor: Abbott Medical Devices

Sex: All

Age: 18+

Code: NCT06526195

Recruiting
Active & Responsive

AMEND TS Early Feasibility Study

for
Symptomatic Functional MR 3 or Greater
Location: Indianapolis IN, New York NY, Houston TX,
Sponsor: Valcare Medical Ltd.

Sex: All

Age: 21+

Code: NCT06951672

Recruiting
Active & Responsive

Trial of the F2 Filter and Delivery System for Embolic Protection During TAVR

for
Aortic Stenosis Treated With TAVI, Aortic Diseases
Location: Indianappolis IN, Detroit MI, Cleveland OH,
Sponsor: EnCompass Technologies, Inc.

Sex: All

Age: 50+

Code: NCT06689839

Recruiting
Active & Responsive

The ME&MG Digital Solution for Autonomous Assessment of Myasthenia Gravis

for
Myasthenia Gravis
Location: Indianapolis IN, Lexington KY, Nashville TN, Durham NC,
Sponsor: Ad scientiam

Sex: All

Age: 18+

Code: NCT05564936

Recruiting
Active & Responsive

AMAZE 1: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight Lose Weight

for
Obesity
Location: Indianapolis IN, Skokie IL, City of Saint Peters MO,
Sponsor: Novo Nordisk A/S

Sex: All

Age: 18+

Code: NCT07339423

Phase3, Recruiting
Active & Responsive

AMAZE 12: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight Maintain Their Weight Loss

for
Obesity
Location: Indianapolis IN, Skokie IL, Anniston AL, Winchester VA,
Sponsor: Novo Nordisk A/S

Sex: All

Age: 18+

Code: NCT07503210

Phase3, Recruiting
Active & Responsive

A Study to Assess the Effectiveness and Safety of IPN10200 Over Time in Adults With Moderate to Severe Wrinkle-like Lines Between the Eyebrows

for
Moderate to Severe Glabellar Lines
Location: Indianapolis IN, Powell OH, Chicago IL, Clarkston MI,
Sponsor: Ipsen

Sex: All

Age: 18 - 70+

Code: NCT07435428

Phase3, Recruiting
Active & Responsive

A Phase IIb Dose-ranging Study to Assess the Efficacy and Safety of GIA632 in Participants With Non-segmental Vitiligo

for
Non-segmental Vitiligo
Location: Indianapolis IN, Troy MI, Murfreesboro TN,
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 18 - 70+

Code: NCT07431177

Phase2, Recruiting
Active & Responsive

A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)

for
Psoriasis, Overweight or Obesity
Location: Indianapolis IN, Plainfield IN, Bowling Green KY,
Sponsor: Eli Lilly and Company

Sex: All

Age: 18+

Code: NCT06857942

Recruiting